First-in-human clinical trial with an alphavirus-based replicon vaccine against HPV-induced cancers

Activity: Talk and presentation › Professional or public presentation › Professional

Period9-Mar-2023
Event titleViruses, Replicons and Vaccines: Opportunities, risks and regulation
Event typeConference
LocationAmsterdam, NetherlandsShow on map
Degree of RecognitionInternational